Title: Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-1014.
1881292-59-6 | 4-(benzyloxy)-5-bromo-2-fluorophenol | AA00I21W | MFCD29044726
1912-24-9 | 6-chloro-2-N-ethyl-4-N-(propan-2-yl)-1,3,5-triazine-2,4-diamine | AA00I2RB | MFCD00041810
1951430-58-2 | Morpholinyl methyl gambogate | AA00I31M | MFCD28064340
195433-54-6 | N-Isopropyl-N-(2-nitrophenyl)methanesulfonamide | AA00I3B3 | MFCD28096637
199274-87-8 | 1-(Methoxymethyl)-4-nitro-1H-pyrazole | AA00I3LV | MFCD16345427
205260-07-7 | 6,7-Dimethoxy-2-methyl-4-(piperazin-1-yl)quinazoline | AA00I3T1 | MFCD09998230
212189-48-5 | Methyl 3-(4-nitrophenoxy)benzoate | AA00I3ZL | MFCD00416158
2192-20-3 | Hydroxyzine dihydrochloride | AA00I46L | MFCD00058200
224584-18-3 | Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(trifluoromethyl)- | AA00I4CV | MFCD20544759
2375-03-3 | Pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodiumsalt, (6a,11b)- | AA00I4IM | MFCD00152612